Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Teleflex Inc | TFX | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 207.27 | 04:29:27 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 207.27 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 177.633 - 276.43 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 207.27 | USD |
Teleflex Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 9.75B | 47.06M | - | 2.98B | 356.33M | 7.57 | 27.37 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Teleflex News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TFX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 210.26 | 213.23 | 205.26 | 207.64 | 254,679 | -2.99 | -1.42% |
| 1 Month | 220.53 | 227.65 | 205.26 | 215.22 | 268,998 | -13.26 | -6.01% |
| 3 Months | 245.58 | 256.85 | 205.26 | 226.87 | 274,393 | -38.31 | -15.60% |
| 6 Months | 186.72 | 257.85 | 177.633 | 225.58 | 275,022 | 20.55 | 11.01% |
| 1 Year | 270.28 | 276.43 | 177.633 | 228.53 | 281,426 | -63.01 | -23.31% |
| 3 Years | 439.59 | 449.375 | 177.633 | 276.02 | 328,533 | -232.32 | -52.85% |
| 5 Years | 275.30 | 449.375 | 177.633 | 300.97 | 293,968 | -68.03 | -24.71% |
Teleflex Description
| Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (25% of 2021 sales), interventional (15%), anesthesia (14%), surgical (13%), interventional urology (12%), original-equipment manufacturing (9%), and all other (12%). Geographic exposure for the business is primarily in the U.S., which accounts for 60% of revenue, with international markets making up the remainder. |
